Archives
-
MK-8745: Translating Aurora A Biology
2026-09-09
A mechanistic and translational framework for using MK-8745, a potent and selective Aurora A inhibitor, to connect mitotic control with apoptosis, lymphoma biology, retinoblastoma research, and tumor xenograft strategy.
-
Prestained Protein Marker for ARID1A Studies
2026-09-09
Build more reliable ARID1A–PTEN–Akt immunoblot workflows with a triple-color ladder that supports separation checks, transfer monitoring, and fluorescence-compatible imaging. Its EDTA-free formulation is especially useful when Phosbind SDS-PAGE or phosphoprotein analysis is part of the experimental design.
-
Lycopene, ERK, and DON-Induced Gut Barrier Injury
2026-09-08
This 2025 study identifies ERK-linked signaling as a mechanistic point through which lycopene limits deoxynivalenol-induced intestinal barrier dysfunction and NLRP3 inflammasome activation in IPEC-J2 cells. Its findings connect oxidative stress, inflammatory signaling, and epithelial barrier injury while providing a pharmacological test of ERK involvement.
-
Ozone, Efferocytosis, and Neuropathic Pain
2026-09-08
The 2024 Frontiers in Immunology study identifies macrophage efferocytosis as a modifiable component of neuropathic pain and links ozone treatment to the AMPK/Gas6-MerTK/SOCS3 pathway. Its inhibitor experiments support a mechanistic model in which improved apoptotic-cell clearance suppresses inflammatory signaling in a chronic constriction injury model.
-
APEX-PS Maps RNA-Binding Proteins in Mitochondria
2026-09-07
The reference study introduces APEX-PS, a functional proximity-labeling strategy that combines compartment-targeted peroxidase labeling with enrichment of crosslinked protein–RNA complexes. Its application identified SYNJ2BP as an outer mitochondrial membrane RNA-binding protein that retains mitochondrial mRNAs during stress and supports recovery of local translation and oxidative phosphorylation.
-
IWP-L6: Precision Porcupine Inhibition Workflows
2026-09-07
IWP-L6 enables controlled Wnt signaling modulation from ligand maturation through developmental and metabolic readouts. This guide translates Porcn enzyme inhibition into practical workflows for HEK293 signaling assays, zebrafish tailfin regeneration, kidney branching studies, and Wnt-driven osteogenesis research.
-
Pentoxifylline and Preterm Monocyte Hyperinflammation
2026-09-05
The reference study shows that pentoxifylline suppresses LPS-driven inflammatory activation in monocytes from preterm and term infants, while also revealing age-dependent differences in surface-marker regulation and IL-10 production. Its integrated use of flow cytometry, functional phagocytosis testing, and TLR4 mRNA analysis provides a useful framework for interpreting neonatal immune modulation in vitro.
-
Resveratrol Rescues Radiation-Induced Endothelial Injury
2026-09-04
The reference study establishes an in vitro endothelial model for quantifying vascular and DNA damage caused by ionizing radiation. Its central finding is a hormetic, dose-dependent response to resveratrol, with 0.1 μM providing complete functional rescue of radiation-induced DNA damage and tube-formation impairment under the reported conditions.
-
Amplex Red for Reliable H2O2 Assays
2026-09-04
Amplex Red delivers sensitive fluorescence-based hydrogen peroxide and peroxidase measurements across mitochondrial, cellular, and enzyme workflows. Its major practical advantage is paired with a major caveat: carboxylesterase activity can generate resorufin without hydrogen peroxide, so robust assays require matrix-specific controls.
-
Capsazepine for Reliable Cell Assays
2026-09-03
Capsazepine (SKU A3279) offers a defined TRPV1 antagonist framework for troubleshooting variable viability, proliferation, and apoptosis assays. This scenario-based guide covers solvent control, concentration design, off-target interpretation, and practical supplier evaluation for more defensible cell-based experiments.
-
Targeted Tea Polyphenol Nanoparticles for AAA Therapy
2026-09-03
This 2025 ACS Applied Materials & Interfaces study develops cRGD-functionalized tea polyphenol nanoparticles that deliver doxycycline selectively to abdominal aortic aneurysm lesions. The platform combines integrin αvβ3 targeting, ROS-responsive drug release, and intrinsic antioxidant activity to address inflammation, oxidative stress, matrix degradation, apoptosis, and calcification while reducing doxycycline-associated organ toxicity.
-
BIBP 3226 Trifluoroacetate in Cardiac Signaling
2026-09-02
BIBP 3226 trifluoroacetate provides a practical pharmacological entry point for separating NPY Y1 and NPFF signaling in cAMP, neuronal, and cardiac models. This workflow-focused guide connects receptor antagonism with adipose-neural arrhythmia research while emphasizing controls, dosing logic, and troubleshooting.
-
Fenipentol Workflows for GI and CHD Research
2026-09-02
Fenipentol, also called 1-Phenyl-1-pentanol, offers a practical small-molecule entry point for secretory physiology, ESR1-oriented mechanism studies, and tissue-resolved Chuanxiong research. This guide connects formulation, secretion assays, SPME-GC×GC-MS, and troubleshooting into an experimentally cautious workflow.
-
Dye Models for Small Biopsy Detection in Pathology
2026-09-01
The reference study evaluates whether colored dyes can reduce the risk of losing or overlooking 0.2–0.3 cm biopsy fragments during routine surgical pathology processing. Merbromin, hematoxylin, and alcian blue improved tissue visibility, but hematoxylin offered the most favorable balance because pathologists reported less toxicity concern and no interference with routine slide examination.
-
SCH772984 as a Causal Probe of NPC Radioresistance
2026-09-01
SCH772984 is an ERK1/2 inhibitor with a useful profile for testing how MAPK signaling intersects with ferroptosis and radiotherapy resistance. This article translates NPC Ang II–HIF-1α–HILPDA findings into a rigorous, hypothesis-driven assay framework while clearly separating evidence from future applications.